Literature DB >> 26803316

Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy: A prospective trial.

Sebastià Sabater1, Ignacio Andrés2, Marina Gascon3, Angeles Rovirosa4, Marimar Sevillano2, Roberto Berenguer2, Cristina Camacho-Lopez4, Manuel Aguayo2, Maria Victoria Villas2, Meritxell Arenas3.   

Abstract

PURPOSE: To evaluate the effects of rectal enemas on rectal doses during postoperative high-dose-rate (HDR) vaginal cuff brachytherapy (VCB). PATIENTS AND METHODS: This prospective trial included 59 patients. Two rectal cleansing enemas were self-administered before the second fraction, and fraction 1 was considered the basal status. Dose-volume histogram (DVH) values were generated for the rectum and correlated with rectal volume variation. Statistical analyses used paired and unpaired t-tests.
RESULTS: Despite a significant 15 % reduction in mean rectal volume (44.07 vs. 52.15 cc, p = 0.0018), 35.6 % of patients had larger rectums after rectal enemas. No significant rectal enema-related DVH differences were observed compared to the basal data. Although not statistically significant, rectal cleansing-associated increases in mean rectal DVH values were observed: D0.1 cc: 6.6 vs. 7.21 Gy; D1 cc: 5.35 vs. 5.52 Gy; D2 cc: 4.67 vs. 4.72 Gy, before and after rectal cleaning, respectively (where Dx cc is the dose to the most exposed x cm(3)). No differences were observed in DVH parameters according to rectal volume increase or decrease after the enema. Patients whose rectal volume increased also had significantly larger DVH parameters, except for D5 %, D25 %, and D50 %. In contrast, in patients whose rectal volume decreased, significance was only seen for D25 % and D50 % (Dx % dose covering x % of the volume). In the latter patients, nonsignificant reductions in D2 cc, D5 cc and V5 Gy (volume receiving at least 5 Gy) were observed.
CONCLUSION: The current rectal enemas protocol was ineffective in significantly modifying rectal DVH parameters for HDR-VCB.

Entities:  

Keywords:  Dose–volume histogram; Endometrial carcinoma; Radiotherapy; Recommendations; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 26803316     DOI: 10.1007/s00066-016-0940-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  23 in total

1.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

2.  Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.

Authors:  Jennifer Hung; Sui Shen; Jennifer F De Los Santos; Robert Y Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-02       Impact factor: 7.038

3.  Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy.

Authors:  S Sabater; Ma M Sevillano; I Andres; R Berenguer; S Machin-Hamalainen; K Müller; M Arenas
Journal:  Strahlenther Onkol       Date:  2013-09-04       Impact factor: 3.621

4.  Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position.

Authors:  Giuseppe Iatì; Antonio Pontoriero; Stefania Mondello; Anna Brogna; Andrea Di Pasquale; Isidora Ielo; Antonio Potami; Giovanna Messina; Costantino De Renzis; Stefano Pergolizzi
Journal:  Brachytherapy       Date:  2014-06-27       Impact factor: 2.362

5.  American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy.

Authors:  William Small; Sushil Beriwal; D Jeffrey Demanes; Kathryn E Dusenbery; Patricia Eifel; Beth Erickson; Ellen Jones; Jason J Rownd; Jennifer F De Los Santos; Akila N Viswanathan; David Gaffney
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

6.  Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients.

Authors:  Oliver Neumann; Anne Kluge; Olga Lyubina; Waldemar Wlodarczyk; Ulrich Jahn; Christhardt Köhler; Volker Budach; Markus Kufeld; Simone Marnitz
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

7.  Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.

Authors:  Sebastia Sabater; Ignacio Andres; Marimar Sevillano; Roberto Berenguer; Santiago Machin-Hamalainen; Meritxell Arenas
Journal:  Brachytherapy       Date:  2013-12-31       Impact factor: 2.362

8.  Post-operative radiotherapy in patients with early stage cervical cancer.

Authors:  Raquel Dávila Fajardo; Rob van Os; Marrije R Buist; Lon Uitterhoeve; Anneke M Westermann; Gemma G Kenter; Coen R N Rasch; Lukas J A Stalpers
Journal:  Gynecol Oncol       Date:  2014-04-29       Impact factor: 5.482

9.  The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy.

Authors:  Jihoon Lim; Blythe Durbin-Johnson; Richard Valicenti; Matthew Mathai; Robin L Stern; Jyoti Mayadev
Journal:  Int J Gynecol Cancer       Date:  2013-07       Impact factor: 3.437

10.  Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity.

Authors:  I Valduvieco; Á Rovirosa; A Herreros; I Romera; I Ríos; C Ascaso; A Sánchez-Reyes; M Arenas; J Pahisa; A Biete
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

View more
  5 in total

1.  Dosimetric evaluation of vaginal cuff brachytherapy planning in cervical and endometrial cancer patients.

Authors:  Katarzyna Sikorska; Agnieszka Zolciak-Siwinska; Adam Kowalczyk; Michał Bijok; Wojciech Michalski; Ewelina Gruszczynska
Journal:  J Contemp Brachytherapy       Date:  2020-06-30

Review 2.  Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?

Authors:  Sebastià Sabater; Ignacio Andres; Veronica Lopez-Honrubia; Roberto Berenguer; Marimar Sevillano; Esther Jimenez-Jimenez; Angeles Rovirosa; Meritxell Arenas
Journal:  Cancer Manag Res       Date:  2017-08-09       Impact factor: 3.989

3.  The clinical impact of removing rectal gas on high-dose-rate brachytherapy dose distributions for gynecologic cancers.

Authors:  Irina Vergalasova; Ronald D Ennis; Mutlay Sayan; Bo Liu; Ning J Yue; Lara Hathout
Journal:  J Appl Clin Med Phys       Date:  2021-01-13       Impact factor: 2.102

4.  Role of non-absorbable oral antibiotics in bowel preparation for intracavitary brachytherapy: effects of rifaximin on rectal dosimetric parameters during vaginal cuff brachytherapy.

Authors:  Sasan Razmjoo; Ali Bagheri; Hodjatollah Shahbazian; Seyed-Mohammad Hosseini; Faezeh Ebrahimian-Tabrizi
Journal:  J Contemp Brachytherapy       Date:  2021-08-24

5.  The usefulness of fleet rectal enemas on high-dose-rate intracavitary cervical cancer brachytherapy. A prospective trial.

Authors:  Ignacio Andres; Manuel Gutierrez-Perez; Maria Pilar Rodriguez-Vela; Roberto Berenguer; Marimar Sevillano; Manuel Aguayo; Meritxell Arenas; Angeles Rovirosa; Yashmina Murria-Perez; Sebastia Sabater
Journal:  J Contemp Brachytherapy       Date:  2017-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.